These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32921251)

  • 21. Phosphorylated α-synuclein in skin nerve fibres differentiates Parkinson's disease from multiple system atrophy.
    Zange L; Noack C; Hahn K; Stenzel W; Lipp A
    Brain; 2015 Aug; 138(Pt 8):2310-21. PubMed ID: 26017579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the Diagnostic Potential of Combined Salivary and Skin Biomarkers in Parkinson's Disease.
    Costanzo M; Galosi E; De Bartolo MI; Gallo G; Leodori G; Belvisi D; Conte A; Fabbrini G; Truini A; Berardelli A; Vivacqua G
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of SNCA variants with α-synuclein of gastric and colonic mucosa in Parkinson's disease.
    Chung SJ; König IR; Lohmann K; Hinrichs F; Kim J; Ryu HS; Lee HJ; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Hong SM; Myung SJ; Klein C
    Parkinsonism Relat Disord; 2019 Apr; 61():151-155. PubMed ID: 30424941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease.
    Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
    Visanji NP; Marras C; Hazrati LN; Liu LW; Lang AE
    Mov Disord; 2014 Apr; 29(4):444-50. PubMed ID: 24375496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of skin α-synuclein using RT-QuIC as a diagnostic biomarker for Parkinson's disease in the Chinese population.
    Li J; Duan S; Yang J; Zheng H; Yuan Y; Tang M; Wang Y; Liu Y; Xia Z; Luo H; Xu Y
    Eur J Med Res; 2024 Feb; 29(1):114. PubMed ID: 38336827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnostic discrimination of cutaneous α-synuclein deposition in Parkinson disease.
    Gibbons CH; Garcia J; Wang N; Shih LC; Freeman R
    Neurology; 2016 Aug; 87(5):505-12. PubMed ID: 27385742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. α-Synuclein Deposition in Sympathetic Nerve Fibers in Genetic Forms of Parkinson's Disease.
    Isonaka R; Goldstein DS; Zhu W; Yoon E; Ehrlich D; Schindler AB; Kokkinis AD; Sabir MS; Scholz SW; Bandres-Ciga S; Blauwendraat C; Gonzalez-Alegre P; Lopez G; Sidransky E; Narendra DP
    Mov Disord; 2021 Oct; 36(10):2346-2357. PubMed ID: 34076298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiological significance of increased α-synuclein deposition in sympathetic nerves in Parkinson's disease: a post-mortem observational study.
    Isonaka R; Sullivan P; Goldstein DS
    Transl Neurodegener; 2022 Mar; 11(1):15. PubMed ID: 35260194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-Synuclein in Peripheral Tissues in Parkinson's Disease.
    Ma LY; Liu GL; Wang DX; Zhang MM; Kou WY; Feng T
    ACS Chem Neurosci; 2019 Feb; 10(2):812-823. PubMed ID: 30714719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Longitudinal Skin Biopsy Study of Phosphorylated Alpha-Synuclein in a Patient With Parkinson Disease and Orthostatic Hypotension.
    Infante R; Scaglione C; Incensi A; Rizzo G; Liguori R; Donadio V
    J Neuropathol Exp Neurol; 2020 Jul; 79(7):813-816. PubMed ID: 32529258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin α-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study.
    Donadio V; Incensi A; El-Agnaf O; Rizzo G; Vaikath N; Del Sorbo F; Scaglione C; Capellari S; Elia A; Stanzani Maserati M; Pantieri R; Liguori R
    Sci Rep; 2018 Sep; 8(1):14246. PubMed ID: 30250046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylated α-synuclein in diluted human serum as a biomarker for Parkinson's disease.
    Chen WR; Chen JC; Chang SY; Chao CT; Wu YR; Chen CM; Chou C
    Biomed J; 2022 Dec; 45(6):914-922. PubMed ID: 34974168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models.
    Sato H; Kato T; Arawaka S
    Rev Neurosci; 2013; 24(2):115-23. PubMed ID: 23314528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
    Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI
    Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of α-Synuclein Species in Plasma Exosomes and the Oligomeric and Phosphorylated α-Synuclein as Potential Peripheral Biomarker of Parkinson's Disease.
    Zheng H; Xie Z; Zhang X; Mao J; Wang M; Wei S; Fu Y; Zheng H; He Y; Chen H; Xu Y
    Neuroscience; 2021 Aug; 469():79-90. PubMed ID: 34186110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
    Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson's disease.
    Wu W; Sung CC; Yu P; Li J; Chung KKK
    PLoS One; 2020; 15(4):e0232019. PubMed ID: 32343709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colonic neuropathology is not associated with autonomic dysfunction in Parkinson's disease.
    Leclair-Visonneau L; Clairembault T; Volteau C; Chapelet G; Le Dily S; Vavasseur F; Coron E; Préterre C; Neunlist M; Péréon Y; Derkinderen P
    Parkinsonism Relat Disord; 2019 Apr; 61():224-227. PubMed ID: 30262379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.